Ellen N. Spremulli

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Heterogeneity of cancer cells from a single human colon carcinoma

Daniel L. Dexter, Ellen N. Spremulli, Zuzana Fligiel et al. · The American Journal of Medicine · 1981 · 167 citations

Tumor Heterogeneity, Medicine, Pathology +7

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

David M. Goldenberg, E. Edmund, Frank H. DeLand et al. · Cancer · 1980 · 124 citations · Full text

Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning Conversations

Gabrielle B. Rocque, J. Nicholas Dionne‐Odom, Chao‐Hui Huang et al. · Journal of Pain and Symptom Management · 2017 · 108 citations · Full text

Nursing, Family Medicine, Advanced Practice Provider +7

Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer.

Kim Ee, Corgan Rl, Scott E. Casper et al. · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1979 · 63 citations